Morphological feature remodeling of intracranial arteries in the context of inflammation and HIV-associated cognitive impairment
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Despite the success of combination antiretroviral therapy (cART), vascular comorbidities, including cerebrovascular disease, are more prominent in people living with HIV (PLWH) compared to people without HIV (PWOH). However, quantitative assessments of cerebrovascular morphometry and their associations with cognitive outcomes in the context of HIV are still limited. In this study, we explore this missing link.
Methods
Magnetic Resonance Angiography (MRA) data, blood markers, and neurocognitive assessments were collected from 73 PWOH subjects ( male : 57, female : 16; age : 53 ± 16) and 99 PLWH subjects ( male : 66, female : 30, age : 53 ± 11). Vessel morphometric features were quantified using intraCranial Artery Feature Extraction (iCafe) to investigate associations between vessel morphometry, markers of monocytes, endothelial cell activation, and cognitive performance.
Results
HIV status predicted a lower total number of branches ( β = − 0.224, p = 0.001, d = − 0.517) and shorter total distal length ( β = − 0.173, p = 0.021, d = –0.370) with a moderate effect size. Total branch number was found to be negatively associated with plasma levels of monocyte markers (sCD14: r = –0.167, p = 0.033; sCD163: r = –0.157, p = 0.045) and positively correlated with white matter cerebral blood flow ( r = 0.550; p ≤ 0.05). HIV status was the strongest predictor of overall cognitive performance in ANCOVA model ( β = –0.219, p = 0.006, d = –0.453).
Conclusions
Our results suggest that cognitive impairment in PLWH is associated with vessel morphology metrics. Monocyte immune activation may contribute to changes in vessel morphology.
